MSF Field Research > 1 Published Research and Commentary > HIV/AIDS > Adherence to antiretroviral therapy: supervision or support?

Please use this identifier to cite or link to this item:     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!

Download this article:
View/Open File Description Size Format
Mills Adherence to antiretroviral - Lancet ID.pdf44KbAdobe PDF

Title: Adherence to antiretroviral therapy: supervision or support?
Authors: Mills, Edward J
Lester, Richard
Ford, Nathan
Affiliation: Faculty of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada; M├ędecins Sans Frontiers, Geneva, Switzerland; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, South Africa
Citation: Lancet Infect Dis 2012; 12(2):97-8
Publisher: Elsevier
Journal: The Lancet Infectious Diseases
Issue Date: Feb-2012
DOI: 10.1016/S1473-3099(11)70354-1
PubMed ID: 22281134
Additional Links:
Abstract: We are entering a new phase in the strategic use of antiretroviral drugs. In addition to dramatically reducing HIV/AIDS-related morbidity and mortality, these drugs have recently shown an important effect in reducing HIV incidence and transmission.
Type: Article
Language: en
MeSH: Antiretroviral Therapy
ISSN: 1474-4457
Rights: Published by Elsevier Reproduced on this site with permission of Elsevier Ltd. Please see for further relevant comment.
Appears in topics: HIV/AIDS

Related articles on PubMed
Author's response.
Bryant L
2013 Dec
See all 81 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.


OR Logo Powered by Open Repository | Cookies


MSF logo MSF Field Research

Jul 5, 2015